Insider Transactions in Q1 2021 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.25%
|
$144,000
$36.78 P/Share
|
Mar 15
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$252,000
$36.79 P/Share
|
Mar 15
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|
Mar 10
2021
|
Johan Wedell Wedellsborg Director |
SELL
Other acquisition or disposition
|
Indirect |
1,029,927
-18.7%
|
-
|
Mar 10
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Other acquisition or disposition
|
Indirect |
1,029,927
+38.78%
|
-
|
Mar 01
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
6,000
-1.0%
|
$210,000
$35.5 P/Share
|
Mar 01
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
9,000
-100.0%
|
$315,000
$35.51 P/Share
|
Mar 01
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
$18,000
$2.0 P/Share
|
Feb 16
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.66%
|
$188,000
$47.09 P/Share
|
Feb 16
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$329,000
$47.08 P/Share
|
Feb 16
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|
Feb 01
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.66%
|
$164,000
$41.97 P/Share
|
Feb 01
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$287,000
$41.99 P/Share
|
Feb 01
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|
Jan 19
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.65%
|
$184,000
$46.56 P/Share
|
Jan 19
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$322,000
$46.51 P/Share
|
Jan 19
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|
Jan 19
2021
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$92,000
$46.52 P/Share
|
Jan 19
2021
|
David N Gill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$22,000
$11.16 P/Share
|
Jan 05
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.65%
|
$196,000
$49.31 P/Share
|
Jan 05
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$343,000
$49.36 P/Share
|
Jan 05
2021
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|